AGÕæÈ˹ٷ½

STOCK TITAN

[6-K] Sinovac Biotech, Ltd Current Report (Foreign Issuer)

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
6-K
Rhea-AI Filing Summary
-
-
-
-
-
Positive
  • None.
Negative
  • None.
-
-
-
-
-

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16 UNDER

THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of July 2025

 

 

 

Commission File Number: 001-32371

 

 

 

SINOVAC BIOTECH LTD.

 

No. 39 Shangdi Xi Rd, Haidian District

Beijing 100085, People’s Republic of China

(Address of principal executive offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

 

Form 20-F     x            Form 40-F     ¨

 

 

 

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  SINOVAC BIOTECH LTD.
   
  By: /s/ Chiang Li
  Name: Dr. Chiang Li
  Title: Chairman of the Board of Directors
   
Date: July 2, 2025

 

 

 

 

Exhibit Index

 

Exhibit 99.1Press Release – Leading Independent Proxy Advisory Firm Glass Lewis Recommends SINOVAC Shareholders Vote to Keep the Current Board in Place

 

 

 

Sinovac Biotech Ltd

NASDAQ:SVA

SVA Rankings

SVA Latest News

SVA Latest SEC Filings

SVA Stock Data

642.44M
25.00M
Pharmaceutical Preparation Manufacturing
Manufacturing
China (Mainland)
Beijing